Global X Management CO LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 279 filers reported holding SAGE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
Global X Management CO LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$94,000
+38.2%
603
+42.2%
0.00%
+100.0%
Q1 2018$68,000
+30.8%
424
+33.3%
0.00%0.0%
Q4 2017$52,000
+246.7%
318
+29.8%
0.00%
Q3 2017$15,000
-11.8%
245
+16.7%
0.00%
-100.0%
Q2 2017$17,000
+88.9%
210
+60.3%
0.00%
Q1 2017$9,000
+50.0%
131
+5.6%
0.00%
Q4 2016$6,0000.0%1240.0%0.00%
Q3 2016$6,000
+50.0%
1240.0%0.00%
Q2 2016$4,0001240.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Third Rock Ventures, LLC 9,773,073$490,901,00052.36%
Ghost Tree Capital, LLC 240,000$12,056,0002.17%
EcoR1 Capital, LLC 112,455$5,649,0001.88%
New Leaf Venture Partners, L.L.C. 43,770$2,199,0001.49%
AlpInvest Partners B.V. 12,195$613,0001.15%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 595,443$29,909,0000.97%
APEX CAPITAL, LLC 190,000$9,544,0000.69%
OAK RIDGE INVESTMENTS LLC 385,770$19,377,0000.43%
Lombard Odier Asset Management (USA) Corp 92,089$4,626,0000.37%
SPHERA FUNDS MANAGEMENT LTD. 65,724$3,301,0000.34%
View complete list of SAGE THERAPEUTICS INC shareholders